Studies assessing genetic variants in the region of the nucleotide-binding oligomerization domain containing 2 (NOD2) gene, which are assumed to play a role in the pathogenesis of inflammatory bowel disease by modulating mucosal immunity [45], showed inconsistent results in PD [46, 47]. The gene discussed is NOD2; the disease is Parkinson disease.